March 29, 2008 - Toshiba America Medical Systems presented the FDA 510(k) cleared Artida ultrasound system, designed to meet the demands of the growing cardiac 4D market, today at the American College of Cardiology's 57th Annual Scientific Session in Chicago, IL.
With Artida's real-time multi-planar reformatting capabilities, physicians should be able to quantify global and regional LV function, including LV ejection fraction, volume and severity of regurgitation. Arbitrary views of the heart not available in 2D imaging are also obtained that can help with surgical planning.
